Annual CFF
$133.57 M
+$36.90 M+38.17%
December 31, 2023
Summary
- As of February 7, 2025, DNTH annual cash flow from financing activities is $133.57 million, with the most recent change of +$36.90 million (+38.17%) on December 31, 2023.
- During the last 3 years, DNTH annual CFF has risen by +$118.66 million (+795.75%).
- DNTH annual CFF is now at all-time high.
Performance
DNTH Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$296.00 K
+$2.49 M+113.48%
September 30, 2024
Summary
- As of February 7, 2025, DNTH quarterly cash flow from financing activities is $296.00 thousand, with the most recent change of +$2.49 million (+113.48%) on September 30, 2024.
- Over the past year, DNTH quarterly CFF has dropped by -$138.14 million (-99.79%).
- DNTH quarterly CFF is now -99.86% below its all-time high of $217.85 million, reached on March 31, 2024.
Performance
DNTH Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$211.08 M
-$138.14 M-39.56%
September 30, 2024
Summary
- As of February 7, 2025, DNTH TTM cash flow from financing activities is $211.08 million, with the most recent change of -$138.14 million (-39.56%) on September 30, 2024.
- Over the past year, DNTH TTM CFF has increased by +$72.64 million (+52.47%).
- DNTH TTM CFF is now -39.93% below its all-time high of $351.42 million, reached on March 31, 2024.
Performance
DNTH TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
DNTH Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +38.2% | -99.8% | +52.5% |
| 3 y3 years | +795.8% | -99.8% | +52.5% |
| 5 y5 years | +795.8% | -99.8% | +52.5% |
DNTH Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +795.8% | -99.9% | +106.1% | -39.9% | +118.3% |
| 5 y | 5-year | at high | +795.8% | -99.9% | +106.1% | -39.9% | +118.3% |
| alltime | all time | at high | +795.8% | -99.9% | +106.1% | -39.9% | +118.3% |
Dianthus Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $296.00 K(-113.5%) | $211.08 M(-39.6%) |
| Jun 2024 | - | -$2.20 M(-101.0%) | $349.23 M(-0.6%) |
| Mar 2024 | - | $217.85 M(-4577.8%) | $351.42 M(+163.1%) |
| Dec 2023 | $133.57 M | -$4.87 M(-103.5%) | $133.57 M(-3.5%) |
| Sep 2023 | - | $138.44 M(>+9900.0%) | $138.44 M(+43.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $0.00(0.0%) | $96.68 M(0.0%) |
| Mar 2023 | - | $0.00(-100.0%) | $96.68 M(0.0%) |
| Dec 2022 | $96.68 M(+548.3%) | - | - |
| Sep 2022 | - | $96.68 M | $96.68 M |
| Dec 2021 | $14.91 M | - | - |
FAQ
- What is Dianthus Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Dianthus Therapeutics?
- What is Dianthus Therapeutics annual CFF year-on-year change?
- What is Dianthus Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Dianthus Therapeutics?
- What is Dianthus Therapeutics quarterly CFF year-on-year change?
- What is Dianthus Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Dianthus Therapeutics?
- What is Dianthus Therapeutics TTM CFF year-on-year change?
What is Dianthus Therapeutics annual cash flow from financing activities?
The current annual CFF of DNTH is $133.57 M
What is the all time high annual CFF for Dianthus Therapeutics?
Dianthus Therapeutics all-time high annual cash flow from financing activities is $133.57 M
What is Dianthus Therapeutics annual CFF year-on-year change?
Over the past year, DNTH annual cash flow from financing activities has changed by +$36.90 M (+38.17%)
What is Dianthus Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of DNTH is $296.00 K
What is the all time high quarterly CFF for Dianthus Therapeutics?
Dianthus Therapeutics all-time high quarterly cash flow from financing activities is $217.85 M
What is Dianthus Therapeutics quarterly CFF year-on-year change?
Over the past year, DNTH quarterly cash flow from financing activities has changed by -$138.14 M (-99.79%)
What is Dianthus Therapeutics TTM cash flow from financing activities?
The current TTM CFF of DNTH is $211.08 M
What is the all time high TTM CFF for Dianthus Therapeutics?
Dianthus Therapeutics all-time high TTM cash flow from financing activities is $351.42 M
What is Dianthus Therapeutics TTM CFF year-on-year change?
Over the past year, DNTH TTM cash flow from financing activities has changed by +$72.64 M (+52.47%)